{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/16/3275181/0/en/MeiraGTx-Announces-Positive-Three-year-Data-from-the-Phase-1-AQUAx-Clinical-Study-of-AAV-hAQP1-for-the-Treatment-of-Grade-2-3-Late-Radiation-Induced-Xerostomia.html", "message": "News view counter 666072 successfully enlarged"}